Carotid Intima-Media Thickness in Children With Familial Hypercholesterolemia

被引:117
作者
Kusters, Dorothe M. [1 ,2 ]
Wiegman, A. [2 ]
Kastelein, John J. P. [1 ]
Hutten, Barbara A. [3 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands
关键词
carotid intima-media thickness; hyperlipoproteinemia type II; pediatrics; STATIN THERAPY; DISEASE;
D O I
10.1161/CIRCRESAHA.114.301430
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Familial hypercholesterolemia (FH) predisposes patients to premature cardiovascular disease, with the process of atherosclerosis initiated in early childhood. Objective: As part of an ongoing trial to assess the efficacy and safety of rosuvastatin in children with FH aged 6 to 17 years, we report the differences in carotid intima-media thickness (cIMT) at baseline between children with FH and their unaffected siblings. Methods and Results: B-mode ultrasound measurements of the carotid artery were made in 196 children with FH and 64 of their siblings. Mean (SE) cIMT in children with FH was significantly greater than that of unaffected siblings (0.398 +/- 0.052 versus 0.377 +/- 0.045 mm; P<0.001). A significantly greater cIMT value was observed before the age of 8 years. Multivariable analyses showed that age, male sex, and presence of FH were independent predictors of cIMT. Conclusions: The difference in mean cIMT between children with FH and their unaffected siblings may be significant as early as age 8 years. This study confirms the need for early cholesterol lowering in this high-risk population. These patients participating in a carefully monitored study will help assess the long-term efficacy on cIMT and safety of statin therapy in young children.
引用
收藏
页码:307 / 310
页数:4
相关论文
共 7 条
[1]   A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors [J].
Cheng, KS ;
Mikhailidis, DP ;
Hamilton, G ;
Seifalian, AM .
CARDIOVASCULAR RESEARCH, 2002, 54 (03) :528-538
[2]  
Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349
[3]   Early statin therapy restores endothelial function in children with familial hypercholesterolemia [J].
de Jongh, S ;
Lilien, MR ;
Roodt, JO ;
Stroes, ESG ;
Bakker, HD ;
Kastelein, JJP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (12) :2117-2121
[4]   Drug therapy of high-risk lipid abnormalities in children and adolescents - A scientific statement from the American heart association atherosclerosis, hypertension, and obesity in youth committee, council of cardiovascular disease in the young, with the council on cardiovascular nursing [J].
McCrindle, Brian W. ;
Urbina, Elaine M. ;
Dennison, Barbara A. ;
Jacobson, Marc S. ;
Steinberger, Julia ;
Rocchini, Albert P. ;
Hayman, Laura L. ;
Daniels, Stephen R. .
CIRCULATION, 2007, 115 (14) :1948-1967
[5]   Statin treatment in children with familial hypercholesterolemia - The younger, the better [J].
Rodenburg, Jessica ;
Vissers, Maud N. ;
Wiegman, Albert ;
van Trotsenburg, A. S. Paul ;
van der Graaf, Anouk ;
de Groot, Eric ;
Wijburg, Frits A. ;
Kastelein, John J. P. ;
Hutten, Barbara A. .
CIRCULATION, 2007, 116 (06) :664-668
[6]   Efficacy and safety of statin therapy in children with familial hypercholesterolemia -: A randomized controlled trial [J].
Wiegman, A ;
Hutten, BA ;
de Groot, E ;
Rodenburg, J ;
Bakker, HD ;
Büller, HR ;
Sijbrands, EJG ;
Kastelein, JJP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (03) :331-337
[7]   Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia [J].
Wiegman, A ;
de Groot, E ;
Hutten, BA ;
Rodenburg, J ;
Gort, J ;
Bakker, HD ;
Sijbrands, EJG ;
Kastelein, JJP .
LANCET, 2004, 363 (9406) :369-370